Effects of neuregulin 3 genotype on human prefrontal cortex physiology

Journal of Neuroscience

Volumn 34, Issue 3, 2014, Pages 1051-1056

  Tost, Heike ^a,b   Callicott, Joseph H ^a   Rasetti, Roberta ^a   Vakkalanka, Radhakrishna ^a,c   Mattay, Venkata S ^a,c   Weinberger, Daniel R ^a,c,d   Law, Amanda J ^a,e  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

ErbB4; Genetics; Neuregulin; Neuroimaging; NRG3; Schizophrenia

Indexed keywords

NEU DIFFERENTIATION FACTOR; NEUREGULIN 3; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE; GENETIC RISK; GENOTYPE; GENOTYPING TECHNIQUE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUREGULIN 3 GENE; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; TASK PERFORMANCE; WORKING MEMORY; YOUNG ADULT;

ERBB4; GENETICS; NEUREGULIN; NEUROIMAGING; NRG3; SCHIZOPHRENIA;

ADULT; FEMALE; GENOTYPE; HUMANS; MALE; NEUREGULINS; PHOTIC STIMULATION; PREFRONTAL CORTEX; PSYCHOMOTOR PERFORMANCE; RISK; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84892376254     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3496-13.2014     Document Type: Article

References (25)

1. Aron AR, Fletcher PC, Bullmore ET, Sahakian BJ, RobbinsTW (2003) Stopsignal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nat Neurosci 6:115-116. CrossRef Medline
2. Balciuniene J, Feng N, Iyadurai K, Hirsch B, Charnas L, Bill BR, Easterday MC, Staaf J, Oseth L, Czapansky-Beilman D, Avramopoulos D, Thomas GH, Borg A, Valle D, Schimmenti LA, Selleck SB (2007) Recurrent 10q22-q23 deletions: a genomic disorder on 10q associated with cognitive and behavioral abnormalities. Am J Hum Genet 80:938-947. CrossRef Medline
3. Bertolino A, Fazio L, Caforio G, Blasi G, Rampino A, Romano R, Di Giorgio A, Taurisano P, Papp A, Pinsonneault J, Wang D, Nardini M, Popolizio T, Sadee W (2009) Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia. Brain 132:417-425. CrossRef Medline
4. Callicott JH, Egan MF, Mattay VS, Bertolino A, Bone AD, Verchinksi B, Weinberger DR (2003a) Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. Am J Psychiatry 160:709-719. CrossRef Medline
5. Callicott JH, Mattay VS, Verchinski BA, Marenco S, Egan MF, Weinberger DR (2003b) Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down. Am J Psychiatry 160:2209-2215. CrossRef Medline
6. Carteron C, Ferrer-Montiel A, Cabedo H (2006) Characterization of a neural-specific splicing form of the human neuregulin 3 gene involved in oligodendrocyte survival. J Cell Sci 119:898-909. CrossRef Medline
7. Chen PL, Avramopoulos D, Lasseter VK, McGrath JA, Fallin MD, Liang KY, Nestadt G, Feng N, Steel G, Cutting AS, Wolyniec P, Pulver AE, Valle D (2009) Fine mapping on chromosome 10q22-q23 implicates Neuregulin 3 in schizophrenia. Am J Hum Genet 84:21-34. CrossRef Medline
8. Egan MF, Straub RE, Goldberg TE, Yakub I, Callicott JH, Hariri AR, Mattay VS, Bertolino A, Hyde TM, Shannon-Weickert C, Akil M, Crook J, Vakkalanka RK, Balkissoon R, Gibbs RA, Kleinman JE, Weinberger DR (2004) Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proc Natl Acad Sci U S A 101:12604-12609. CrossRef Medline
9. Fallin MD, Lasseter VK, Wolyniec PS, McGrath JA, Nestadt G, Valle D, Liang KY, Pulver AE (2003) Genomewide linkage scan for schizophrenia susceptibility loci among Ashkenazi Jewish families shows evidence of linkage on chromosome 10q22. Am J Hum Genet 73:601-611. CrossRef Medline
10. Faraone SV, Hwu HG, Liu CM, Chen WJ, Tsuang MM, Liu SK, Shieh MH, Hwang TJ, Ou-Yang WC, Chen CY, Chen CC, Lin JJ, Chou FH, Chueh CM, Liu WM, Hall MH, Su J, Van Eerdewegh P, Tsuang MT (2006) Genome scan of Han Chinese schizophrenia families from Taiwan: confirmation of linkage to 10q22.3. Am J Psychiatry 163:1760-1766. CrossRef Medline
11. Hariri AR, Weinberger DR (2003) Imaging genomics. Br Med Bull 65:259-270. CrossRef Medline
12. Huffaker SJ, Chen J, Nicodemus KK, Sambataro F, Yang F, Mattay V, Lipska BK, Hyde TM, Song J, Rujescu D, Giegling I, Mayilyan K, Proust MJ, Soghoyan A, Caforio G, Callicott JH, Bertolino A, Meyer-Lindenberg A, Chang J, Ji Y, et al. (2009) A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia. Nat Med 15:509-518. CrossRef Medline
13. Kao WT, Wang Y, Kleinman JE, Lipska BK, Hyde TM, Weinberger DR, Law AJ (2010) Common genetic variation in Neuregulin 3 (NRG3) influences risk for schizophrenia and impacts NRG3 expression in human brain. Proc Natl Acad Sci U S A 107:15619-15624. CrossRef Medline
14. Koechlin E, Ody C, Kouneiher F (2003) The architecture of cognitive control in the human prefrontal cortex. Science 302:1181-1185. CrossRef Medline
15. Meier S, Strohmaier J, Breuer R, Mattheisen M, Degenhardt F, Muhleisen TW, Schulze TG, Nothen MM, Cichon S, Rietschel M, Wust S (2013) Neuregulin 3 is associated with attention deficits in schizophrenia and bipolar disorder. Int J Neuropsychopharmacol 16:549-556. CrossRef Medline
16. Meyer-Lindenberg A, Straub RE, Lipska BK, Verchinski BA, Goldberg T, Callicott JH, Egan MF, Huffaker SS, Mattay VS, Kolachana B, Kleinman JE, Weinberger DR (2007) Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition. J Clin Invest 117:672-682. CrossRef Medline
17. Morar B, DragoviæM, Waters FA, Chandler D, Kalaydjieva L, Jablensky A (2011) Neuregulin 3 (NRG3) as a susceptibility gene in a schizophrenia subtype with florid delusions and relatively spared cognition. Mol Psychiatry 16:860-866. CrossRef Medline
18. Nixon DC, Prust MJ, Sambataro F, Tan HY, Mattay VS, Weinberger DR, Callicott JH (2011) Interactive effects of DAOA (G72) and catechol-Omethyltransferase on neurophysiology in prefrontal cortex. Biol Psychiatry 69:1006-1008. CrossRef Medline
19. Rasetti R, Weinberger DR (2011) Intermediate phenotypes in psychiatric disorders. Curr Opin Genet Dev 21:340-348. CrossRef Medline
20. Rasetti R, Sambataro F, Chen Q, Callicott JH, Mattay VS, Weinberger DR (2011) Altered cortical network dynamics: a potential intermediate phenotype for schizophrenia and association with ZNF804A. Arch Gen Psychiatry 68:1207-1217. CrossRef Medline
21. Rasetti R, Mattay VS, White MG, Sambataro F, Podell JE, Zoltick B, Chen Q, Berman KF, Callicott JH, Weinberger DR (2014) Altered hippocampalparahippocampal function during stimulus encoding: a potential indicator of genetic liability for schizophrenia. JAMA Psychiatry, in press.
22. Sambataro F, Mattay VS, Thurin K, Safrin M, Rasetti R, Blasi G, Callicott JH, Weinberger DR (2013) Altered cerebral response during cognitive control: a potential indicator of genetic liability for schizophrenia. Neuropsychopharmacology 38:846-853. CrossRef Medline
23. Tan HY, Sust S, Buckholtz JW, Mattay VS, Meyer-Lindenberg A, Egan MF, Weinberger DR, Callicott JH (2006) Dysfunctional prefrontal regional specialization and compensation in schizophrenia. Am J Psychiatry 163: 1969-1977. CrossRef Medline
24. van Erp TG, Guella I, Vawter MP, Turner J, Brown GG, McCarthy G, Greve DN, Glover GH, Calhoun VD, Lim KO, Bustillo JR, Belger A, Ford JM, Mathalon DH, Diaz M, Preda A, Nguyen D, Macciardi F, Potkin SG (2013) Schizophrenia miR-137 locus risk genotype is associated with dorsolateral prefrontal cortex hyperactivation. Biol Psychiatry. Advance online publication. Retrieved Aug. 1, 2013. doi:10.1016/j.biopsych.2013.06.016. CrossRef Medline
25. Xu B, Woodroffe A, Rodriguez-Murillo L, Roos JL, van Rensburg EJ, Abecasis GR, Gogos JA, Karayiorgou M (2009) Elucidating the genetic architecture of familial schizophrenia using rare copy number variant and linkage scans. Proc Natl Acad Sci U S A 106:16746-16751. CrossRef Medline